Pfizer Limited reports a change in its board or management
In short
Pfizer Limited informed the NSE on August 22, 2026, that a director/KMP/SMP has resigned. No figures, breakdowns, scheme names, or financial amounts were given. In simple terms, the company is telling investors that one of its key management or board officials is stepping down. No closing date, validity period, or deadline was stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.